These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 19488782)
1. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782 [TBL] [Abstract][Full Text] [Related]
2. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212 [TBL] [Abstract][Full Text] [Related]
3. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma]. Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849 [TBL] [Abstract][Full Text] [Related]
4. The determination of stage in nonmuscle urothelial carcinoma: Staining pattern of caspase-8. Türk NŞ; Eskiçorapçi S; Aybek Z; Tuncay L Indian J Pathol Microbiol; 2018; 61(2):192-196. PubMed ID: 29676355 [TBL] [Abstract][Full Text] [Related]
5. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas. Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between tumor suppressor genes p14ARF and p53 expression and biological behavior of pancreatic carcinoma]. Chen XL; Zhang QH; Ni QX Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):868-71. PubMed ID: 12895341 [TBL] [Abstract][Full Text] [Related]
7. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway. Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850 [TBL] [Abstract][Full Text] [Related]
9. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
10. Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia. Buchynska LG; Nesina IP; Kashuba EV Exp Oncol; 2007 Dec; 29(4):287-94. PubMed ID: 18199985 [TBL] [Abstract][Full Text] [Related]
11. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells. Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819 [TBL] [Abstract][Full Text] [Related]
13. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636 [TBL] [Abstract][Full Text] [Related]
14. Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Amatya VJ; Takeshima Y; Inai K Mod Pathol; 2004 Jun; 17(6):705-10. PubMed ID: 15073599 [TBL] [Abstract][Full Text] [Related]
15. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations. Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407 [TBL] [Abstract][Full Text] [Related]
16. MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. Walter RF; Mairinger FD; Ting S; Vollbrecht C; Mairinger T; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J Br J Cancer; 2015 Mar; 112(5):883-90. PubMed ID: 25668009 [TBL] [Abstract][Full Text] [Related]
17. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B; Gazzeri S; Brambilla C; Brambilla E Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548 [TBL] [Abstract][Full Text] [Related]
18. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization. Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444 [TBL] [Abstract][Full Text] [Related]
19. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882 [TBL] [Abstract][Full Text] [Related]
20. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]